Skip to content
★ Sign in to follow
PF

Patrick F. Smith

Président, Développement Intégré des Médicaments
Total declarations
26
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (13 ops.)
€1.2M

Latest filing published 08 Oct 2024 for Certara, Inc., €54k.

Filing timeline

BuySale
Patrick F. Smith

Insider track record

Disclosed buys
0
Disclosed sells
13

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Patrick F. Smith: trading record in brief

Patrick F. Smith (chief executive) discloses dealings in Certara, Inc. to SEC (Form 4). Over a trading history stretching from 1 November 2021 to 7 October 2024, the count stands at 26 filings.

Sales make up the whole of the open-market record (13 sales, €1.2M). The rest of the record consists of 9 share grants and 4 option exercises. So far in 2024, the count stands at no purchases and 8 sales.

Most recently, on 8 October 2024, the filings show an open-market sale worth €54k in Certara, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Patrick F. Smith

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations13 total
  • ▼
    PRESIDENT, DRUG DEV SOLUTIONSExecutivesCertara, Inc.
    59,661 USD34SEC
    5,409 shares@ US$11.035.0% of flowCommon StockSEC:0001415889-24-024874:0
  • ◇
    PRESIDENT, DRUG DEV SOLUTIONSExecutivesCertara, Inc.
    0SEC
    7,151 shares0Common StockSEC:0001415889-24-024816:0
  • ▼
    PRESIDENT, DRUG DEV SOLUTIONSExecutivesCertara, Inc.
    88,225 USD35SEC
    5,264 shares@ US$16.767.5% of flowCommon StockSEC:0001415889-24-010291:0
  • ◆
    PRESIDENT, DRUG DEV SOLUTIONSExecutivesCertara, Inc.
    27,392 USD22SEC
    1,532 shares@ US$17.882.3% of flowCommon StockSEC:0001415889-24-010073:0
  • ▼
    PRESIDENT, DRUG DEV SOLUTIONSExecutivesCertara, Inc.
    90,000 USD35SEC
    5,000 shares@ US$18.007.6% of flowCommon StockSEC:0001415889-24-004633:0
  • ▼
    PRESIDENT, INTEGRATED DRUG DEVExecutivesCertara, Inc.
    411,691 USD38SEC
    19,104 shares@ US$21.5535.2% of flowCommon StockSEC:0001415889-23-009326:0
  • ◆
    PRESIDENT, INTEGRATED DRUG DEVExecutivesCertara, Inc.
    36,462 USD22SEC
    1,532 shares@ US$23.803.1% of flowCommon StockSEC:0001415889-23-005808:0
  • ▼
    PRESIDENT, INTEGRATED DRUG DEVExecutivesCertara, Inc.
    32,177 USD40SEC
    2,387 shares@ US$13.482.9% of flowCommon StockSEC:0001415889-22-011348:0
  • ◆
    PRESIDENT, INTEGRATED DRUG DEVExecutivesCertara, Inc.
    15,214 USD22SEC
    1,244 shares@ US$12.231.4% of flowCommon StockSEC:0001415889-22-011013:0
  • ▼
    PRESIDENT, INTEGRATED DRUG DEVExecutivesCertara, Inc.
    177,100 USD39SEC
    10,000 shares@ US$17.7115.9% of flowCommon StockSEC:0001415889-22-008824:0
  • ▼
    PRESIDENT, INTEGRATED DRUG DEVExecutivesCertara, Inc.
    191,600 USD39SEC
    10,000 shares@ US$19.1616.4% of flowCommon StockSEC:0001415889-22-006381:0
  • ◆
    PRESIDENT, INTEGRATED DRUG DEVExecutivesCertara, Inc.
    32,907 USD22SEC
    1,532 shares@ US$21.482.7% of flowCommon StockSEC:0001415889-22-003827:0
  • ◆
    PRESIDENT, INTEGRATED DRUG DEVExecutivesCertara, Inc.
    0SEC
    3,631 shares0Common StockSEC:0001415889-21-005033:0

13 of 13 declarations